بدائل البحث:
systemic decrease » systemic disease (توسيع البحث), systemic diseases (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
_ systemic » _ systematic (توسيع البحث), _ systems (توسيع البحث)
a large » _ large (توسيع البحث)
systemic decrease » systemic disease (توسيع البحث), systemic diseases (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
_ systemic » _ systematic (توسيع البحث), _ systems (توسيع البحث)
a large » _ large (توسيع البحث)
-
1
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
منشور في 2025"…(C) Mutualism also promotes an increase in network connectance when introduced into assembled communities, while stopping mutualistic interactions from entering an assembled system slowly decreases it. (D) As a result, the introduction of mutualistic interactions promotes a growth in complexity in communities where it was once established as low, while stopping the introduction of further mutualistic interactions causes a slight decrease in complexity. …"
-
2
-
3
ECoG timescales decrease during spatial attention.
منشور في 2025"…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …"
-
4
-
5
-
6
-
7
-
8
Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes
منشور في 2025الموضوعات: -
9
Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes
منشور في 2025الموضوعات: -
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
18
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
19
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
20